R&D Systems™ Recombinant Human BLMH/Bleomycin Hydrolase Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its ability to hydrolyze Met-AMC. The specific activity is >500 pmol/min/μg, as measured under the described conditions.

Specifications

• Accession Number: Q13867
• For Use With (Application): Enzyme Activity
• Formulation: Supplied as a 0.2 μm filtered solution in Tris, NaCl, Glycerol and DTT.
• Gene ID (Entrez): 642
• Molecular Weight (g/mol): M.W. (Observed): 45-50 kDa, reducing conditions; M.W. (theoretical): 53 kDa
• Name: BLMH/Bleomycin Hydrolase
• Quantity: 10 μg
• Source: E. coli-derived human BLMH/Bleomycin Hydrolase protein Ser2-Glu455, with an N-terminal Met and 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -70°C as supplied. 3 months, -70°C under sterile conditions after opening.
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: BLMH
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BLMH/Bleomycin Hydrolase